Presentation is loading. Please wait.

Presentation is loading. Please wait.

Algorithm for the treatment of testosterone deficiency syndrome (TDS)

Published byRodolphe Pellerin Modified over 5 years ago

Similar presentations

Presentation on theme: "Algorithm for the treatment of testosterone deficiency syndrome (TDS)"— Presentation transcript:

1 Algorithm for the treatment of testosterone deficiency syndrome (TDS)
Algorithm for the treatment of testosterone deficiency syndrome (TDS). *Report adverse events to MedEffect Canada ( Algorithm for the treatment of testosterone deficiency syndrome (TDS). *Report adverse events to MedEffect Canada ( Alvaro Morales et al. CMAJ 2015;187: ©2015 by Canadian Medical Association

Download ppt "Algorithm for the treatment of testosterone deficiency syndrome (TDS)"

Similar presentations

David N. Juurlink, et al. CMAJ 2009;180: (7) [Epub]

David N. Juurlink, et al. CMAJ 2009;180: (7) [Epub]
Enrollment and Outcomes Fan Fan Hou, et al. N Engl J Med 2006;354:131-40.

Enrollment and Outcomes Fan Fan Hou, et al. N Engl J Med 2006;354:
The Diagnostic and Statistical Manual of Mental Disorders.

The Diagnostic and Statistical Manual of Mental Disorders.
Patient disposition Dichtl W, et al. Am J Cardiol. 2008;102:743-8 AVR = aortic valve replacement; MDCT = multidetector computed tomographic.

Patient disposition Dichtl W, et al. Am J Cardiol. 2008;102:743-8 AVR = aortic valve replacement; MDCT = multidetector computed tomographic.
OFEV ® (nintedanib) safety Safety data INPULSIS ® -1 & -2 These slides are provided by Boehringer Ingelheim for medical to medical education only. Last.

OFEV ® (nintedanib) safety Safety data INPULSIS ® -1 & -2 These slides are provided by Boehringer Ingelheim for medical to medical education only. Last.
Discontinuation of medication after nonfatal event: MI

Discontinuation of medication after nonfatal event: MI
Rates of Ambulatory Care Visits for Treating Adverse Drug Events (VADEs): Trend 1995–2001 Data: National Ambulatory Medical Care Survey and National Hospital.

Rates of Ambulatory Care Visits for Treating Adverse Drug Events (VADEs): Trend 1995–2001 Data: National Ambulatory Medical Care Survey and National Hospital.
Mean scores for symptoms of mental illness between 1994/95 and 2004/05 in participants aged 10–11 years (A), between 1996/97 and 2007/08 in those aged.

Mean scores for symptoms of mental illness between 1994/95 and 2004/05 in participants aged 10–11 years (A), between 1996/97 and 2007/08 in those aged.
FIGURE. Many Canadian farmers now use a loophole in Health Canada policy in order to import unapproved antibiotics that promote growth of farm animals.

FIGURE. Many Canadian farmers now use a loophole in Health Canada policy in order to import unapproved antibiotics that promote growth of farm animals.
Tips Need to Consider When Organizing a College Event

Tips Need to Consider When Organizing a College Event
Results of random-effects meta-analysis of association between use of angiotensin-converting-enzyme (ACE) inhibitors or angiotensin-receptor blockers and.

Results of random-effects meta-analysis of association between use of angiotensin-converting-enzyme (ACE) inhibitors or angiotensin-receptor blockers and.
برنامه راهبردی پیشگیری و کنترل بیماری های قلبی عروقی

برنامه راهبردی پیشگیری و کنترل بیماری های قلبی عروقی
The proportion of immigrant children and youth aged 12 to 19 years and 15 to 17 years who had consulted a dental professional in the last year (2009/2010)

The proportion of immigrant children and youth aged 12 to 19 years and 15 to 17 years who had consulted a dental professional in the last year (2009/2010)
ماجستير إدارة المعارض من بريطانيا

ماجستير إدارة المعارض من بريطانيا
EVITA Trial design: Smokers admitted with an acute coronary syndrome were randomized to varenicline 1 mg twice daily (n = 151) vs. placebo (n = 151). Study.

EVITA Trial design: Smokers admitted with an acute coronary syndrome were randomized to varenicline 1 mg twice daily (n = 151) vs. placebo (n = 151). Study.
Persistence of first tumour necrosis factor alpha inhibitor (TNFi) by TNFi Kaplan-Meier plot of time (years) to discontinuation of treatment by TNFi. (A)

Persistence of first tumour necrosis factor alpha inhibitor (TNFi) by TNFi Kaplan-Meier plot of time (years) to discontinuation of treatment by TNFi. (A)
Volume 124, Issue 4, Pages (April 2003)

Volume 124, Issue 4, Pages (April 2003)
Short-Bowel Syndrome Clinical Gastroenterology and Hepatology

Short-Bowel Syndrome Clinical Gastroenterology and Hepatology
Toxicity spectra and rankings in the subgroup analysis based on each specific grade 1-5 adverse event and cancer type. Toxicity spectra and rankings in.

Toxicity spectra and rankings in the subgroup analysis based on each specific grade 1-5 adverse event and cancer type. Toxicity spectra and rankings in.
Database-specific risk of ventricular arrhythmia associated with current use of azithromycin compared with current use of amoxicillin (2-stage random-effects.

Database-specific risk of ventricular arrhythmia associated with current use of azithromycin compared with current use of amoxicillin (2-stage random-effects.

Similar presentations

Ads by Google